← Leaderboards
L Jackson Roberts
Vanderbilt University
$17,065,377
Attributed
$17,833,138
Total exposure
18
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.6M · FY2005–18$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$30,246,659 · 20
By mechanism
P01$15,261,433 · 6
R37$6,452,001 · 1
R01$4,253,884 · 4
P50$3,090,762 · 3
M01$1,188,579 · 6
Top collaborators
- Manisha N Patel5 shared
Most similar at Vanderbilt University
Same institution · by research overlap
- Claus Schneider$9,629,126
- Yu Shyr$30,935,638
- Alan R. Brash$11,970,167
- C. Henrique Serezani$10,097,790
- Thomas J Montine$57,372,903
Others in their field
Top investigators on “Oxidative Stress”
- Leonardo Trasande · New York University School Of Medicine$57,471,048
- Rosalind J Wright · Icahn School Of Medicine At Mount Sinai$36,739,005
- Claire Gmachl · Princeton University$34,397,540
- Akram N Alshawabkeh · Northeastern University$31,872,089
- Gervasio A Lamas · Mount Sinai Medical Center (Miami Beach)$31,629,832
- Robert O Wright · Brigham And Women'S Hospital$30,479,869
Research focus
Oxidative StressProteinsLipid PeroxidationOxidationPeroxidationPathway InteractionsF2-IsoprostanesProstaglandinsAdductPharmacologyFree RadicalsPreventAntioxidantsClinical ResearchPlasmaCellsFunctional DisorderHuman SubjectLipidsIn VivoIsoprostanesInjuryPharmaceutical PreparationsReporting
Grant awards (67)
Isoprostane Products and HDL Dysfunction$477,701
P01 · FY2018 · HL · contact PI
Isoprostane Products and HDL Dysfunction$477,701
P01 · FY2017 · HL · contact PI
Isoprostane Products and HDL Dysfunction$477,701
P01 · FY2016 · HL · contact PI
Gamma-ketoaldehydes in epileptogenesis$341,140
R01 · FY2016 · NS
Research Center for Pharmacology & Drug Toxicology$1,741,256
P01 · FY2015 · GM · contact PI
Isoprostane Products and HDL Dysfunction$467,557
P01 · FY2015 · HL · contact PI
Gamma-ketoaldehydes in epileptogenesis$341,140
R01 · FY2015 · NS
Mechanisms of Leukotriene, Resolvin and Protectin Biosynthesis$296,465
P01 · FY2015 · GM · contact PI
Inhibition of Lipid Peroxidation in Subarachnoid Hemorrage$283,219
P01 · FY2015 · GM · contact PI
Mass Spectrometry Core$70,609
P01 · FY2015 · GM · contact PI
Administrative & Biostatistics Core$70,074
P01 · FY2015 · GM · contact PI
Research Center for Pharmacology & Drug Toxicology$1,807,879
P01 · FY2014 · GM · contact PI
Isoprostane Products and HDL Dysfunction$474,173
P01 · FY2014 · HL · contact PI
Inhibition of Lipid Peroxidation in Subarachnoid Hemorrage$372,625
P01 · FY2014 · GM · contact PI
Gamma-ketoaldehydes in epileptogenesis$337,033
R01 · FY2014 · NS
Mechanisms of Leukotriene, Resolvin and Protectin Biosynthesis$290,213
P01 · FY2014 · GM · contact PI
Gamma-ketoaldehydes in epileptogenesis$164,987
R01 · FY2014 · NS
Mass Spectrometry Core$69,908
P01 · FY2014 · GM · contact PI
Administrative & Biostatistics Core$69,727
P01 · FY2014 · GM · contact PI
Research Center for Pharmacology & Drug Toxicology$1,847,423
P01 · FY2013 · GM · contact PI
Inhibition of Lipid Peroxidation in Subarachnoid Hemorrage$494,455
P01 · FY2013 · GM · contact PI
Gamma-ketoaldehydes in epileptogenesis$351,223
R01 · FY2013 · NS
Mechanisms of Leukotriene, Resolvin and Protectin Biosynthesis$266,658
P01 · FY2013 · GM · contact PI
Administrative & Biostatistics Core$65,151
P01 · FY2013 · GM · contact PI
Mass Spectrometry Core$65,115
P01 · FY2013 · GM · contact PI
Research Center for Pharmacology & Drug Toxicology$1,916,261
P01 · FY2012 · GM · contact PI
Inhibition of Lipid Peroxidation in Subarachnoid Hemorrage$513,361
P01 · FY2012 · GM · contact PI
Mechanisms of Leukotriene, Resolvin and Protectin Biosynthesis$274,730
P01 · FY2012 · GM · contact PI
Administrative & Biostatistics Core$67,992
P01 · FY2012 · GM · contact PI
Mass Spectrometry Core$67,680
P01 · FY2012 · GM · contact PI
Research Center for Pharmacology & Drug Toxicology$2,235,799
P01 · FY2011 · GM · contact PI
Research Center for Pharmacology and Drug Toxicology$1,413,576
P50 · FY2010 · GM · contact PI
Structural Identification of Prostaglandin Conjugates$726,997
R37 · FY2010 · GM · contact PI
Research Center for Pharmacology and Drug Toxicology$1,451,327
P50 · FY2009 · GM · contact PI
Structural Identification of Prostaglandin Conjugates$712,534
R37 · FY2009 · GM · contact PI
Structural Identification of Prostaglandin Conjugates$691,361
R37 · FY2008 · GM · contact PI
Reactive gamma-Ketoaldehydes in Dementia$263,503
R01 · FY2008 · AG · contact PI
CALORIC RESTRICTION, OXIDATIVE DAMAGE AND LONGEVITY$94
M01 · FY2008 · RR · contact PI
Structural Identification of Prostaglandin Conjugates$690,842
R37 · FY2007 · GM · contact PI
Oxidative Stress Na Channel Gating and Arrhythmias$296,280
R01 · FY2007 · HL · contact PI
Reactive gamma-Ketoaldehydes in Dementia$261,049
R01 · FY2007 · AG · contact PI
CALORIC RESTRICTION, OXIDATIVE DAMAGE AND LONGEVITY$1,988
M01 · FY2007 · RR · contact PI
Structural Identification of Prostaglandin Conjugates$694,891
R37 · FY2006 · GM · contact PI
Oxidative Stress Na Channel Gating and Arrhythmias$306,979
R01 · FY2006 · HL · contact PI
Reactive gamma-Ketoaldehydes in Dementia$261,016
R01 · FY2006 · AG · contact PI
CALORIC RESTRICTION, OXIDATIVE DAMAGE AND LONGEVITY$75,087
M01 · FY2006 · RR · contact PI
Structural Identification of Prostaglandin Conjugates$618,971
R37 · FY2005 · GM
CALORIC RESTRICTION, OXIDATIVE DAMAGE AND LONGEVITY$341,258
M01 · FY2005 · RR
Oxidative Stress Na Channel Gating and Arrhythmias$328,956
R01 · FY2005 · HL
Reactive gamma-Ketoaldehydes in Dementia$259,510
R01 · FY2005 · AG
OXIDATIVE STRESS AND MULTIORGAN FAILURE IN THE ELDERLY$116,515
M01 · FY2005 · RR
Caloric Restriction, Oxidative Damage and Longevity$625,027
M01 · FY2004 · RR
Structural Identification of Prostaglandin Conjugates$601,077
R37 · FY2004 · GM
Reactive gamma-Ketoaldehydes in Dementia$300,290
R01 · FY2004 · AG
Oxidative Stress and Multiorgan Failure in the Elderly$28,610
M01 · FY2004 · RR
Structural Identification of Prostaglandin Conjugates$583,700
R37 · FY2003 · GM
Structural Identification of Prostaglandin Conjugates$566,828
R37 · FY2002 · GM
MISOPROSTOL INHIBITION OF SYSTEMIC MAST CELL ACTIVATION$0
M01 · FY2002 · RR
Metabolic Disposition Of Cyclopentenone Eicosanoids$0
P50 · FY2002 · GM
Structural Identification of Prostaglandin Conjugates$564,800
R37 · FY2001 · GM
MISOPROSTOL INHIBITION OF SYSTEMIC MAST CELL ACTIVATION$0
M01 · FY2001 · RR
Metabolic Disposition Of Cyclopentenone Eicosanoids$0
P50 · FY2001 · GM
MISOPROSTOL INHIBITION OF SYSTEMIC MAST CELL ACTIVATION$0
M01 · FY2001 · RR
MISOPROSTOL INHIBITION OF SYSTEMIC MAST CELL ACTIVATION$0
M01 · FY2001 · RR
STRUCTURAL IDENTIFICATION OF PROSTAGLANDIN CONJUGATES$440,778
R01 · FY2000 · GM
CLINICAL PHARMACOLOGY OF LIPID PEROXIDATION AND ANTIOXIDANT AGENTS$225,859
P50 · FY2000 · GM
MISOPROSTOL INHIBITION OF SYSTEMIC MAST CELL ACTIVATION$0
M01 · FY2000 · RR